Cigna (CI) Price to Sales (2017 - 2026)

Cigna has disclosed Price to Sales across 10 years of filings, most recently posting 1.02 for Q2 2026.

• In Q2 2026, Price to Sales fell 22.62% year-over-year to 1.02; the TTM figure through Jun 2026 stood at 0.26 (down 23.4% YoY), while the FY2025 annual figure was 0.26, down 13.76% from the prior year.
• Price to Sales came in at 1.02 for Q2 2026 at Cigna, down from 1.03 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 2.16 in Q4 2022 to a low of 1.0 in Q4 2025.
• Average Price to Sales over 5 years is 1.5, with a median of 1.58 recorded in 2023.
• Year-over-year, Price to Sales jumped 33.23% in 2022 and sank 32.8% in 2024.
• Over 5 years, Price to Sales stood at 2.16 in 2022, then fell by 20.78% to 1.71 in 2023, then sank by 32.8% to 1.15 in 2024, then declined by 13.1% to 1.0 in 2025, then grew by 1.56% to 1.02 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 1.02 in Q2 2026, 1.03 in Q1 2026, and 1.0 in Q4 2025.